Deregulation of PHF2 has been linked with various malignancies, such as renal cell carcinoma and breast cancer, as abnormal PHF2 activity disrupts the expression of oncogenes and tumor suppressor genes, facilitating tumor growth and progression [72]. This evidence concerns the gene PHF2 and renal cell carcinoma.